Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Diagnosis Track

Variations in SUV and textural indices in breast tissue satellite to breast cancer compared to normal breast tissue in FDG-PET.

Sarah Boughdad, Christophe Nioche, Fanny ORLHAC, Laurence Champion and Irene Buvat
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 1058;
Sarah Boughdad
5SHFJ Orsay France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Nioche
3Commissariat a l'Energie Atomique Orsay France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fanny ORLHAC
2CEA-SHFJ IMIV Orsay France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurence Champion
4Institut Curie Hopital Rene Huguenin Saint Cloud France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene Buvat
1IMIV Orsay France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1058

Objectives: Breast cancer (BC) is the most common cancer in women in western countries. Previous studies have shown a significant correlation between histological data and SUV or textural indices (TI) measured from PET images. However to the best of our knowledge, satellite breast tissue to BC has not been fully explored in terms of SUV and TI. The purpose of this study was to assess SUV and TI in breast tissue satellite to the breast cancer in comparison to normal breast tissue (NBT) to point out differences that might assist patient treatment planning.

Methods: BC group was defined from a population of women who underwent a F18-FDG-PET/CT for initial staging of BC. SUV (max, mean and peak), TLG (total lesion glycolysis, mL) and TI (homogeneity, entropy, LRE, SRE, LGZE and HGZE) were measured in a tumor volume of interest (T-VOI) and in a satellite VOI (S-VOI) drawn next to the T-VOI but outside any tumor border or any suspicious foci especially in multifocal BC. The same S-VOI was mirrored to the contralateral breast (CL-VOI). NBT group was defined from a population of 307 women who underwent a F18-FDG-PET/CT for initial staging of various cancers (with no previous history of BC, local therapy, endometrial, or ovarian cancers) and a B-VOI was drawn in both breasts for comparison. Mann-Whitney (M-W) tests were used to compare SUV and TI between groups: S-VOI vs T-VOI, CL-VOI, B-VOI and CL-VOI vs B-VOI.

Results: One hundred and fifty seven T-VOI, 129 S-VOI and 111 CL-VOI were drawn in the BC group. A total of 95 B-VOI (14.4mL+/-6) drawn in the NBT group were matched according to VOI size to CL-VOI and used for all M-W tests. The SUV and TI measured in the T-VOI significantly differed from those measured in S-VOI (p<0.0001, table 1). There were significant differences in SUV, TLG and TI between S-VOI and CL-VOI (p<0.05, table 1) and between S-VOI and the 95 B-VOI of the NBT group (p<0.0001, table 1). There was no significant difference between CL-VOI and the 95B-VOI except for TLG (p=0.004). The only difference in VOI size was between T-VOI and S-VOI groups while S-VOI, CL-VOI and B-VOI had non significantly different volumes (Anova test: p=0.9). Some values measured in S-VOI were significantly different in patients with breast conservative surgery vs radical mastectomy (TLG: p=0.02), but also as a function of the tumor grade: I and II vs III (LRE: p=0.027), and when in situ carcinoma was diagnosed (homogeneity: p=0.04; SRE: p=0.049; HGZE: p=0.046). There was no difference in S-VOI as a function of the histological type CCI vs CLI, molecular subtype or presence of an inflammatory stroma.

View this table:
  • View inline
  • View popup

Table 1: Average value and standard deviation for the different index and in the different VOI, [asterisk] p value <0.05 of the M-W tests between S-VOI and T-VOI, S-VOI and CL-VOI, S-VOI and B-VOI (95 VOI).

Conclusion: Significant differences were found between breast tissue satellite to breast tumor and contralateral breast in BC patients with a strong correlation to presence of in situ carcinoma for some textural indices. Those results showed that variations in breast tissue satellite to breast tumor is not random and should be further investigated to help with treatment planning.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Variations in SUV and textural indices in breast tissue satellite to breast cancer compared to normal breast tissue in FDG-PET.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Variations in SUV and textural indices in breast tissue satellite to breast cancer compared to normal breast tissue in FDG-PET.
Sarah Boughdad, Christophe Nioche, Fanny ORLHAC, Laurence Champion, Irene Buvat
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 1058;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Variations in SUV and textural indices in breast tissue satellite to breast cancer compared to normal breast tissue in FDG-PET.
Sarah Boughdad, Christophe Nioche, Fanny ORLHAC, Laurence Champion, Irene Buvat
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 1058;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Diagnosis Track

  • Immunohistochemical analysis of Gastrin-Releasing-Peptide receptor (GRPr) and Prostate-Specific- Membrane Antigen (PSMA) in primary prostate cancer: comparison with radiolabeled GRPr antagonist (68Ga-RM2) PET/CT
  • Relationship between FDG PETCT imaging and CA 125 levels in treated patients with Ovarian cancers - Can FDG PETCT define and predict the disease burden in clinically suspected recurrence ?
  • Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of SUVmax
Show more Oncology, Clinical Diagnosis Track

Breast Cancer Posters

  • The importance of 18F-FDG PET/CT in staging male breast carcinoma
  • Correlation between 18F-FDG PET/CT standardized uptake value with prognostic factors and gene expression profiles in breast cancer: Single center study from Azerbaijan
  • Relationship between tumor markers, Ca 15-3 and Ca 125, levels and Sodium-18 Fluoride Positron Emission Tomography Scan in breast cancer bone metastasis
Show more Breast Cancer Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire